EUVIMEDEUVIMED entdecken
EditorialOpen Access · CC BY-NC 4.0

Antibody-drug conjugates in breast oncology: new standards, emerging challenges, and future directions

Prarthna V Bhardwaj, Paolo Tarantino iD, Ilana Schlam iD

Therapeutic Advances in Medical Oncology · 2026-03 · 18

DOI: 10.1177/17588359261432056 ↗

Kurz gefasst

Editorial in der Zeitschrift Therapeutic Advances in Medical Oncology, online erschienen am 13.03.2026. Verfasst von Prarthna V Bhardwaj und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology Oncology, University of Massachusetts Medical School-Baystate, Springfield, MA, USA. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

demonstrated a consistent improvement in PFS and OS compared to the physicians’ choice of treatment (typically chemotherapy), with a 50% reduction in the risk of progression ( n = 1828, hazard ratio (HR) 0.50, 95% confidence interval (CI), 0.36–0.68, I 2 = 82%,

Schlagwörter

Stichwörter der Autor:innen

ADCsantibody-drug conjugatesbreast cancer

Autor:innen und Institutionen

  • Division of Hematology Oncology, University of Massachusetts Medical School-Baystate, Springfield, MA, USA.
  • Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA.
  • Harvard Medical School, Boston, MA, USA.
  • Breast Oncology Program, Dana-Farber Brigham Cancer Center, 450 Brookline Ave., Boston, MA 02215, USA.

ORCID-Profile: Paolo Tarantino, Ilana Schlam

Zitieren

APA

Bhardwaj, P. V., Tarantino, P., & Schlam, I. (2026). Antibody-drug conjugates in breast oncology: new standards, emerging challenges, and future directions. Therapeutic Advances in Medical Oncology, 18. https://doi.org/10.1177/17588359261432056

Vancouver

Bhardwaj PV, Tarantino P, Schlam I. Antibody-drug conjugates in breast oncology: new standards, emerging challenges, and future directions. Therapeutic Advances in Medical Oncology. 2026;18. doi:10.1177/17588359261432056

BibTeX
@article{Bhardwaj2026,
  author = {Bhardwaj, Prarthna V and Tarantino, Paolo and Schlam, Ilana},
  title = {Antibody-drug conjugates in breast oncology: new standards, emerging challenges, and future directions},
  journal = {Therapeutic Advances in Medical Oncology},
  year = {2026},
  volume = {18},
  doi = {10.1177/17588359261432056}
}
Kostenlos starten →